Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 41Obesity 9Anovulation 8Infertility 7Insulin Resistance 6Overweight 2Non-alcoholic Fatty Liver Disease 2Hirsutism 2Diabetes, Gestational 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Racism 1Prostatic Neoplasms 1Pregnancy Complications 1Mouth Neoplasms 1Metabolic Syndrome 1Hyperandrogenism 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1Diabetes Mellitus, Type 2 1Breast Cancer Female 1Body Weight 1Amenorrhea 1Acne Vulgaris 1

Interventions

drospirenone and ethinyl estradiol combination 3Ethinyl Estradiol 2Topiramate 1Metformin 1Glycoprotein Hormones, alpha Subunit 1Cyproterone acetate, ethinyl estradiol drug combination 1Cyproterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hyperandrogenism × Metformin × Clear all
NCT00428311 2007-01-31

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Hospital Universitario Ramon y Cajal

Phase 4 Completed
50 enrolled

Hirsutism, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡